2016 Market News "Global Exiqon AS - Product Pipeline Analysis" Forecast 2025 For Research, Share, Industry Trend

Description-

Summary

Exiqon A/S (Exiqon) is a medical device company that develops, manufactures and markets molecular diagnostic test products. The company offers RNA, microRNA and LNA oligos products. Its RNA products comprise isolation, ISH, GapmeRs, qPCR and microarray systems. Exiqon offers LNA oligo products such as LNA oligo shop and LNA design tools. The company also provides RNA sequencing, microRNA PCR services, online RNA sequencing data analysis, RNA isolation, custom pharma and array services. It offers its gene expression analysis products for the life sciences industry and cellular based diagnostic tests for the diagnostics industry. Exiqon is headquartered in Vedbaek, Denmark.

This report is a source for data, analysis, and actionable intelligence on the companys portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

To Browse a Report Detail with TOC @ http://www.researchmoz.us/exiqon-as-exq-product-pipeline-analysis-2016-update-report.html

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Exiqon AS
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

To Free Sample Report With TOC @ http://www.researchmoz.us/enquiry.php?type=S&repid=746089

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Exiqon A/S Company Snapshot 6
Exiqon A/S Company Overview 6
Exiqon A/S Pipeline Products and Clinical Trials Overview 7
Exiqon A/S Pipeline Analysis Overview 9
Key Facts 9
Exiqon A/S - Major Products and Services 10
Exiqon A/S Pipeline Products by Development Stage 11
Exiqon A/S Pipeline Products Overview 13
Colon Cancer Test - Stage III Patient 13
Colon Cancer Test - Stage III Patient Product Overview 13
Colon Cancer Test - Stage IV Patient 14
Colon Cancer Test - Stage IV Patient Product Overview 14
Diagnostic Test - Prostate Cancer Stratification 15
Diagnostic Test - Prostate Cancer Stratification Product Overview 15
Diagnostic Test - T-Cell Lymphoma 16
Diagnostic Test - T-Cell Lymphoma Product Overview 16
Genetic Test - Prostate Cancer 17
Genetic Test - Prostate Cancer Product Overview 17
miRNA Biomarker - Cancer of Unknown Primary 18
miRNA Biomarker - Cancer of Unknown Primary Product Overview 18
miRNA Test - Endometrial Cancer 19
miRNA Test - Endometrial Cancer Product Overview 19
miRNA Test - Lung Cancer 20
miRNA Test - Lung Cancer Product Overview 20
miRNA test-Ovarian 21
miRNA test-Ovarian Product Overview 21
miRNAbiomarker - Breast cancer 22
miRNAbiomarker - Breast cancer Product Overview 22
Prognosis Test - Prostate Cancer 23
Prognosis Test - Prostate Cancer Product Overview 23
Prostate Cancer - Early Detection Test 24
Prostate Cancer - Early Detection Test Product Overview 24
Prostate Cancer - Treatment Selection Test 25
Prostate Cancer - Treatment Selection Test Product Overview 25
Ran Biomarker Diagnostic Test 26
Ran Biomarker Diagnostic Test Product Overview 26
Exiqon A/S - Key Competitors 27
Exiqon A/S - Key Employees 28
Exiqon A/S - Locations And Subsidiaries 29
Head Office 29
Other Locations & Subsidiaries 29
Recent Developments 30
Exiqon A/S, Recent Developments 30
Apr 26, 2016: Exiqon: First Quarter 2016 Supports Continued Strong Momentum 30
Feb 08, 2016: Exiqon realizes full year 2015 profitability driven by strong revenue growth 30
Nov 06, 2015: Accelerated RNA discovery by XploreRNA presented to audience at Genome Festival 31
Oct 26, 2015: Third consecutive profitable quarter with continued strong growth 31
Aug 25, 2015: Exiqon: Continued strong performance in the second quarter with 24% growth and profitability 32
Jun 30, 2015: Exiqon integrates RNAseq workflow in unique cloud-computing environment, XploreRNA 33
Jun 30, 2015: Exiqon launches ExiLERATE LNA qPCR product portfolio for analysis of mRNA and lncRNA 33
Dec 18, 2014: Exiqon launches new Research Use Only kit for PCR analysis of colon cancer samples 34
Dec 18, 2014: Exiqon launches new Research Use Only kit miRSIGN miR-21 Oncogene assay 34
May 07, 2014: Exiqon Announces Interim Report For The Period 1 January - 31 March 2014 34
Appendix 36
Methodology 36
About GlobalData 36
Contact Us 36
Disclaimer 36

List of Tables
Exiqon A/S Pipeline Products and Clinical Trials Overview 7
Exiqon A/S Pipeline Products by Equipment Type 7
Exiqon A/S Pipeline Products by Indication 8
Exiqon A/S, Key Facts 9
Exiqon A/S, Major Products and Services 10
Exiqon A/S Number of Pipeline Products by Development Stage 11
Exiqon A/S Pipeline Products Summary by Development Stage 12
Colon Cancer Test - Stage III Patient - Product Status 13
Colon Cancer Test - Stage III Patient - Product Description 13
Colon Cancer Test - Stage IV Patient - Product Status 14
Colon Cancer Test - Stage IV Patient - Product Description 14
Diagnostic Test - Prostate Cancer Stratification - Product Status 15
Diagnostic Test - Prostate Cancer Stratification - Product Description 15
Diagnostic Test - T-Cell Lymphoma - Product Status 16
Diagnostic Test - T-Cell Lymphoma - Product Description 16
Genetic Test - Prostate Cancer - Product Status 17
Genetic Test - Prostate Cancer - Product Description 17
miRNA Biomarker - Cancer of Unknown Primary - Product Status 18
miRNA Biomarker - Cancer of Unknown Primary - Product Description 18
miRNA Test - Endometrial Cancer - Product Status 19
miRNA Test - Endometrial Cancer - Product Description 19
miRNA Test - Lung Cancer - Product Status 20
miRNA Test - Lung Cancer - Product Description 20
miRNA test-Ovarian - Product Status 21
miRNA test-Ovarian - Product Description 21
miRNAbiomarker - Breast cancer - Product Status 22
miRNAbiomarker - Breast cancer - Product Description 22
Prognosis Test - Prostate Cancer - Product Status 23

To Enquire Regarding This Report @ http://www.researchmoz.us/enquiry.php?type=E&repid=746089

ResearchMoz is the world’s fastest growing collection of market research reports worldwide. Our database is composed of current market studies from over 100 featured publishers worldwide. Our market research databases integrate statistics with analysis from global, regional, country and company perspectives. ResearchMoz’s service portfolio also includes value-added services such as market research customization, competitive landscaping, and in-depth surveys, delivered by a team of experienced Research Coordinators.

For More Information Kindly Contact:

ResearchMoz Global Pvt. Ltd.
90 State Street,
Albany, NY 12207,
United States
866-997-4948 (Us-Canada Toll Free),
+1-518-621-2074,

This release was published on openPR.